New Rochelle, NY, January 10, 2012 C. Noel Bairey Merz, MD, FACC, will be awarded the inaugural Journal of Women's Health Award for Outstanding Achievement in Women's Health Research, to be presented at the 20th Annual Congress on Women's Health, March 16-18, 2012 in Washington, DC. Physicians, nurses, ...

(Mary Ann Liebert, Inc./Genetic Engineering News) C. Noel Bairey Merz, M.D., F.A.C.C., will be awarded the inaugural Journal of Women's Health Award for Outstanding Achievement in Women's Health Research, to be presented at the 20th Annual Congress on Women's Health, March 16-18, 2012, in Washington, D.C.

Merz Aesthetics today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved XEOMIN for the temporary improvement in the appearance of moderate to severe glabellar lines, or frown lines between the eyebrows, in adult patients.

Stress management programs like Transcendental Meditation should be implemented to significantly reduce depression, heart attacks, strokes and deaths in coronary heart disease patients, according to a new editorial written by a Cedars-Sinai Heart Institute physician, C. Noel Bairey Merz, MD, and published in Archives of Internal Medicine. C. Noel Bairey ...

Merz Pharmaceuticals, LLC, maker of XEOMIN, a botulinum toxin type A free from accessory proteins, today announced the launch of the "Make Your Mark" campaign.

Merz Pharmaceuticals, LLC announced today that the Centers for Medicare and Medicaid Services (CMS) has granted a unique Healthcare Common Procedure Coding System (HCPCS) billing code, Q2040, for Xeomin®(incobotulinumtoxinA). Merz expects that this unique billing code, which will become effective on April 1, 2011, will help simplify the billing ...

Following news of the acquisition of BioForm Medical, Inc. earlier this year, Merz Aesthetics, the new business unit of Merz Pharma Group, makes its debut at the prestigious American Society of Aesthetic Plastic Surgeons (ASAPS) annual meeting with the announcement of the U.S. Food and Drug Administration's (FDA) recent approval ...

GREENSBORO, N.C. , Feb. 17 /- Stretch marks can make even the most beautiful women feel insecure and self-conscious. Approximately 90% of pregnant women and 70% of adolescent females have stretch marks, and they also commonly occur in people who have lost weight within a brief time period. ...

Today Merz Pharma entered the Irish Healthcare market with Denzapine, the first generic form of clozapine available in Ireland. Denzapine is an atypical antipsychotic agent used in treatment-resistant schizophrenia (TRS) which has been available to prescribe in the UK since February 2004. Denzapine is available in four tablet ...

Merz Pharmaceuticals announced Xeomin®, the first botulinum toxin type A free from complexing proteins has been granted an extension of indication for post-stroke spasticity of the upper limb presenting with flexed wrist and clenched fist in adults in various European countries.

FRANKFURT, Nov. 18 /- Today, Merz Pharmaceuticals announced Xeomin®, the first botulinum toxin type A free from complexing proteins has been granted an extension of indication for post-stroke spasticity of the upper limb presenting with flexed wrist and clenched fist in adults in various European countries. Xeomin® was already ...

C. Noel Bairey Merz, M.D., an internationally recognized authority on women's heart health, will receive the American Heart Association's 2009 Women in Cardiology Mentoring Award at the organization's Scientific Sessions 2009, to be held in Orlando at the Orange County Convention Center Nov. 14-Nov. 18.